Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Amarin reported $609M in Market Capitalization this March of 2023, considering the latest stock price and the number of outstanding shares.

Market Capitalization Change
AbbVie ABBV:US USD 281.15B 4.65B
Alnylam Pharmaceuticals ALNY:US USD 24.83B 4.41B
Amarin AMRN:US USD 609M 120M
AstraZeneca AZN:LN USD 174.08B 252.77M
BioCryst Pharmaceuticals BCRX:US USD 1.57B 568M
DBV Technologies DBVT:US USD 328M 11M
Esperion Therapeutics ESPR:US USD 142M 317M
GlaxoSmithKline GSK:LN GBP 58.52B 341.4M
Halozyme Therapeutics HALO:US USD 5.17B 2.52B
Heron Therapeutics HRTX:US USD 180M 117M
Intercept Pharmaceuticals ICPT:US USD 560M 48M
Ionis Pharmaceuticals IONS:US USD 5.11B 253M
Nektar Therapeutics NKTR:US USD 133M 292M
Neurocrine Biosciences NBIX:US USD 9.87B 1.61B
Novartis NOVN:VX USD 190.76B 10.17B